Some patients may experience a “dry mouth” sensation after the procedure, but this should dissipate once the effects of the oral conscious sedation pill wear off. Temporary dizziness, headache, and lightheadedness may also be present in some patients after treatment; however, if these effects occur at all, they are rarely serious and fade quickly in most patients. Many people experience what may be considered a good side effect of oral conscious sedation: an “amnesic” effect from the sedation pill that leaves them with little to no memory of the dental procedure even taking place!
During clinical development for the approved indications, 18560 patients were exposed to XARELTO . These included 7111 patients who received XARELTO 15 mg or 20 mg orally once daily for a mean of 19 months (5558 for 12 months and 2512 for 24 months) to reduce the risk of stroke and systemic embolism in nonvalvular atrial fibrillation (ROCKET AF); 6962 patients who received XARELTO 15 mg orally twice daily for three weeks followed by 20 mg orally once daily to treat DVT or PE (EINSTEIN DVT , EINSTEIN PE), 10 mg or 20 mg orally once daily (EINSTEIN Extension, EINSTEIN CHOICE) to reduce the risk of recurrence of DVT and/or PE; and 4487 patients who received XARELTO 10 mg orally once daily for prophylaxis of DVT following hip or knee replacement surgery (RECORD 1-3).